Toronto, Canada
ODAIA, founded in 2018 and headquartered in Canada, is carving a niche in the intersection of AI, Biotechnology, and Machine Learning. The company offers a unique AI-Powered Pharma Solutions approach, focusing on maximizing commercial impact for life sciences companies through its flagship product, MAPTUAL.
This cloud-based solution integrates data and behavioral science with AI to provide a comprehensive understanding of healthcare professionals (HCPs) and their decision-making processes throughout the customer journey. The emphasis on 'Customer Science' allows ODAIA to deliver innovative engagement strategies, thereby increasing its appeal to the pharmaceutical sector.
In its latest fundraising round, ODAIA secured a significant $25.00M Series B investment on 01 May 2023. The financing was led by a consortium of investors, including Panache Ventures, Flint Capital, and MaRS IAF, among others, underlining strong investor confidence in its mission and growth prospects.
-logo.jpg "Vayo (Acquired by Gong)"){kind=logo}
dunnhumby
Lexer